Biggest News Aggregation in the World
📰 Biologic Response Modifiers News

Biologic Response Modifiers News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Biologic Response Modifiers. Real-time updates on events, politics, business and more.

High-risk stage III-IV melanoma patients treated with pembrolizumab report better quality of life

Patients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than patients who received the previous standard-of-care treatment with either ipilimumab or high-dose interferon.
United States Josephm Unger Sapna Patel Emily Henderson Development Agreement National Clinical Trials Network

Biologic Response Modifiers Market Size 2021 | Is Projected to Reach USD 150.2 BN With 5.4% CAGR by 2027

Biologic Response Modifiers Market Size 2021 | Is Projected to Reach USD 150.2 BN With 5.4% CAGR by 2027 Biologic Response Modifiers Market Size 2021 | Is Projected to Reach USD 150.2 BN With 5.4% CAGR by 2027 April 16, 2021 | by admin | The global Biologic Response Modifiers market generated revenue of around USD 135.3 billion in 2020 and anticipated to grow at a CAGR of over 5.4% during the forecast period from 2021 to 2027 to reach around USD 150.2 billion in 2027. Biolog...
United States Asia Pacific Chris Smith Bristol Myers Squibb Janssen Inc Merck Co

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science